LearnGlossaryMarketStocksSuperinvestorsSign in

RPID

Rapid Micro Biosystems, Inc.

Healthcare · $50M market cap

Verdict

We can't put a fair value on RPID right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth-39.7% a year✗
Sales growth12.6% a year✓
Free cash flow growth—?
Return on invested capital-62.7%✗

Follow RPID

Track it on your watchlist and see the full analysis. Free.

Create a free account

About Rapid Micro Biosystems, Inc.

Rapid Micro Biosystems, Inc. operates as a life sciences technology firm, supplying advanced solutions for identifying microbial impurities in the production processes of pharmaceuticals, medical devices, and personal care goods across North America, Europe, and Asia. Central to their offerings is the Growth Direct platform, a comprehensive system comprising the Growth Direct instrument, specialized disposable…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works